First Patient Dosed in Chemotherapy Induced Peripheral Neuropathy Clinical Trial
LONDON, July 17, 2026 /PRNewswire/ -- Ananda Pharma Limited is a UK-based biopharmaceutical company developing regulatory approved cannabidiol medicines to treat complex, chronic conditions. It has lead programmes in endometriosis and chemotherapy induced peripheral neuropathy (CIPN). The...
LONDON, July 17, 2026 /PRNewswire/ -- Ananda Pharma Limited is a UK-based biopharmaceutical company developing regulatory approved cannabidiol medicines to treat complex, chronic conditions. It has lead programmes in endometriosis and chemotherapy induced peripheral neuropathy (CIPN). The...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.